Adjuvant chemotherapy guidance for pT1-3N0-1 breast cancer patients with HR(+), HER2(-) subtype: a cohort study based on the SEER database

database[Title] 2022-01-30

Summary:

CONCLUSIONS: In this study, a well-validated nomogram and a risk stratification model was built. Patients in the high-risk group should receive CHT, while patients in low-risk group may be exempt from CHT.

Link:

https://pubmed.ncbi.nlm.nih.gov/35071473/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12QQbiNmM99eUQGIX1JjHIKcROC1Vzv4sOS-2S_LNI19uG_Yrk&fc=20220129225649&ff=20220130094144&v=2.17.5

From feeds:

📚BioDBS Bibliography » database[Title]

Authors:

Nan Wen, Juanjuan Qiu, Li Xu, Yu Wang, Jia Zhang, Yanyan Xie, Qing Lv, Zhenggui Du

Date tagged:

01/30/2022, 09:43

Date published:

01/24/2022, 06:00